The finding of the long persistence of IgM antibodies in some participants of the post-COVID-19 cohort warrants additional investigation, particularly the determination of whether the persistence of IgM is related to persistent infection with SARS-CoV-2. The gene discussed is CD40LG; the disease is COVID-19.